1
Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions
Condition(s):Squamous Lntraepithelial Lesions of Vulva; Neoplasms, Squamous Cell; Vulvar HSILLast Updated:April 13, 2021Terminated
E7 T-Cell Receptor, TCR: 14 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
E7 TCR T Cell Induction Immunotherapy for Stage IIB-IVA Cervical Cancer
Condition(s):Uterine Cervical NeoplasmsLast Updated:December 15, 2021Terminated
3
E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer
Condition(s):Papillomavirus Infections; Oropharyngeal NeoplasmsLast Updated:February 24, 2022Terminated
4
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Condition(s):HPV-Associated Cervical Carcinoma; HPV-Related Carcinoma; HPV-Related Malignancy; HPV Positive Oropharyngeal Squamous Cell Carcinoma; HPV-Related Adenocarcinoma; HPV-Related Adenosquamous Carcinoma; HPV-Related Squamous Cell Carcinoma; HPV-Related Anal Squamous Cell Carcinoma; HPV-Related Penile Squamous Cell Carcinoma; HPV-Related Vulvar Squamous Cell Carcinoma; HPV-Related Endocervical Adenocarcinoma; Cervical Cancer; Oropharynx Cancer; Anal Cancer; Vulvar Cancer; Penile Cancer; Vaginal CancerLast Updated:March 28, 2023Suspended
5
Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers
Condition(s):Human Papillomavirus (HPV) 16+ Relapsed/Refractory CancerLast Updated:May 25, 2022Terminated
6
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Condition(s):Cervical Cancer; Throat Cancer; Oropharynx Cancer; Anal Cancer; Vulva Cancer; Vaginal Cancer; Penile Cancer; Metastatic Cancer; HPV-Related Malignancy; HPV-Related Carcinoma; HPV-Related Cervical Carcinoma; HPV-Related Squamous Cell Carcinoma; HPV-Related Adenocarcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma; HPV-Associated Vaginal Adenocarcinoma; HPV-Related Adenosquamous Carcinoma; HPV-Related Endocervical Adenocarcinoma; HPV-Related Anal Squamous Cell Carcinoma; HPV-Related Penile Squamous Cell Carcinoma; HPV-Related Vulvar Squamous Cell Carcinoma; HPV Positive Rectal Squamous Cell CarcinomaLast Updated:March 27, 2023Recruiting
7
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
Condition(s):Papillomavirus Infections; Cervical Intraepithelial Neoplasia; Carcinoma In Situ; Vulvar Neoplasms; Vulvar DiseasesLast Updated:September 6, 2023Recruiting
8
A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer
Condition(s):Papillomavirus Infections; Oropharyngeal NeoplasmsLast Updated:September 22, 2020Withdrawn
9
E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial Neoplasia
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:July 15, 2020Withdrawn
10
Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
Condition(s):NeuroblastomaLast Updated:July 28, 2023Active, not recruiting